CTA Meeting on Paediatric ARVs: Introducing the Global Accelerator for Paediatric Formulations
5 December 2016 | Geneva, Switzerland (By invitation only)
On 5 December 2016, the Global Pediatric Antiretroviral Commitment-to-Action (CTA) partner organizations convened key stakeholders in the paediatric ARV space to accelerate joint efforts to identify innovative approaches to fast-track development and introduce priority paediatric formulations. This meeting built on previous efforts to develop a collaborative framework to accelerate development of paediatric ARVs, and, potentially, serve as a model for tuberculosis and other disease areas.
The objectives of the meeting were to first assess the level of stakeholder support for the revised proposal for a Global Accelerator for Paediatric Formulations and, second, provided the framework is supported, to identify and generate consensus around key action steps required for its implementation. To that end, the CTA convened leaders from across the HIV community and after presenting the revised framework, two panel discussions helped better define some of the concrete steps to be taken in order to start implementing the principles of the Global Accelerator for Paediatric Formulations, at global as well as at country level. Key considerations shared during the meeting are summarized and will be used to inform the next steps to be taken during the first phase of implementation of the Global Accelerator for Paediatric Formulations.